cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Emerging opportunities for nicotinamide N-methyltransferase (NNMT) clinical translation Nicotinamide N-Methyltransferase in Cardiovascular Diseases:

Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target US20200102274A1 Quinoline derived small molecule inhibitors of nicotinamide n methyltransferase (nnmt) and uses thereof Google Patents Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Selective and membrane permeable small molecule inhibitors of nicotinamide N methyltransferase reverse high fat diet induced obesity in mice PMC

SKU: 96552126766 · From lagence-mr.com